We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
+28.34%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$1B
AUM Growth
+$157M
(+18%)
Cap. Flow
-$40.2M
Cap. Flow
% of AUM
-4.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
APLS
Apellis Pharmaceuticals
APLS
|
+$26M |
| 2 |
Harmony Biosciences
HRMY
|
+$14.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
ALX Oncology
ALXO
$262M
| $716M | 71.37% |
9,699,925
| – | – |
|
|
2
Harmony Biosciences
HRMY
$1.94B
| $117M | 11.7% |
3,063,194
-441,430
| -13% | -$14.2M |
|
|
AKRO
3
DELISTED
Akero Therapeutics
AKRO
| $49.2M | 4.9% |
2,200,778
| – | – |
|
4
Pharvaris
PHVS
$2.4B
| $40.8M | 4.07% |
2,303,310
| – | – |
|
|
IMPL
5
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $33.6M | 3.35% |
2,759,791
| – | – |
|
|
ELEV
6
DELISTED
Elevation Oncology
ELEV
| $20.3M | 2.02% |
2,608,167
| – | – |
|
|
CMPI
7
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $14.6M | 1.45% |
3,673,374
| – | – |
|
|
MTCR
8
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $10.5M | 1.05% |
3,059,123
| – | – |
|
|
VRNA
9
DELISTED
Verona Pharma
VRNA
| $887K | 0.09% |
161,897
| – | – |
|
|
APLS
10
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-411,471
| Closed | -$26M |
|
Similar funds
OCWP
FFP
BDA
PHC
SA
ACC
NRCM
IP